USPharmacist | Weekly News Update


May 6, 2015
  • Taking Too Much of OTC Dietary Supplements Could Increase Cancer Risk

    While some people think more must be better when it comes to OTC vitamins and dietary supplements, pharmacists might consider cautioning them otherwise. A recent conference presentation revealed that exceeding daily dose recommendations on those products has been linked to increased cancer risk. Here are the details.

  • Statins: Cost-Effective for 75-Plus Cohort but Side-Effects Could Limit Use

    Most guidelines recommending statins to reduce cardiovascular risk only go up to age 75. A new study, however, finds that treating patients that age and older can be beneficial with one important proviso: Potential side effects could reverse any advantages. Here is the cost-benefit analysis.

  • New Analysis Looks at Longer Term Cancer Risks of Hormone Therapy

    In response to studies linking some postmenopausal hormone replacement therapies to increased breast cancer risk, many clinicians and patients have opted for short-term use as a safer alternative. But is it less risky in the long term? A new study begins to answer that question.

  • Despite Black Box Warning, Droperidol Found to Be Safe for ED Sedation

    Prior to 2001, droperidol often was used in U.S. emergency departments to help manage patients who were violent and/or aggressive because of issues such as mental illness, intoxication, or attempts to harm themselves. That changed after FDA added a black box warning related to heart rhythm issues. Find out why a new Australian study disputes the findings leading to the FDA action.

U.S. Pharmacist Social Connect